Niche Market Focus Novelion Therapeutics specializes in rare diseases and orphan treatments, creating opportunities to connect with niche healthcare providers, specialized clinics, and organizations focused on rare disease management that require tailored solutions and partnerships.

Global Partnership Strategy The company's licensing agreements with partners like Recordati in Japan suggest openness to expanding market reach through strategic collaborations, presenting avenues for proposing joint ventures, distribution partnerships, or regional market development opportunities.

Growing with Mergers Following its merger with QLT Inc. and acquisition activities, Novelion is in a phase of expansion and integration, which indicates potential needs for technology, communication solutions, and consulting services to support operational scalability.

Limited Revenue Scale With revenue estimated between 1 to 10 million dollars and a relatively small employee base, the company may be seeking cost-effective, innovative solutions to boost sales or expand product reach, presenting opportunities in affordable technology or targeted marketing.

Recent Regulatory Scrutiny Recent legal issues related to promotional practices highlight the importance of compliance and regulatory consulting services, which could be valuable for the company to ensure adherence to FDA and legal standards while expanding sales efforts.